UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.057

Sortiert nach

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Journal of clinical oncology, 2020-06, Vol.38 (16), p.1824-1835

2020

Link zum Volltext

Verfügbarkeit prüfen

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Journal of clinical oncology, 2022-08, Vol.40 (23), p.2546-2556

2022

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4008-4008

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 2000-02, Vol.18 (3), p.623-631

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 1996-08, Vol.14 (8), p.2345-2352

1996

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

Journal of clinical oncology, 2024-02, Vol.42 (5), p.500

2024

Link zum Volltext

Verfügbarkeit prüfen

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Journal of clinical oncology, 2006-02, Vol.24 (4), p.612-618

2006

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial

Journal of clinical oncology, 1997-09, Vol.15 (9), p.3093-3099

1997

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin, 5-FU, and leucovorin (FOLFOX) in advanced biliary tract cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4106-4106

2011

Link zum Volltext

Verfügbarkeit prüfen

The association of novel recurrent in-frame gene fusions with prognosis of diffuse gastric cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.34-34

Kim, Hark K.

2019

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer

Journal of clinical oncology, 2019-01, Vol.37 (1), p.33-43

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2493-2501

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of a new cancer/testis antigen from small cell lung cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.21182-21182

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4463-4473

2004

Link zum Volltext

Verfügbarkeit prüfen

The clinical implication of comprehensive geriatric assessment in elderly Korean cancer patients receiving systemic chemotherapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e19562-e19562

2010

Link zum Volltext

Verfügbarkeit prüfen

Proteome analysis of malignant pleural effusion

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e22194-e22194

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics of an incident cohort of patients with resected squamous cell carcinoma of the head and neck (SCCHN) in the United Kingdom

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5540-5540

2011

Link zum Volltext

Verfügbarkeit prüfen

Economic burden and patterns of care in patients with advanced hepatocellular carcinoma

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.487-487

2020

Link zum Volltext

Verfügbarkeit prüfen

Are there any candidates for adjuvant hysterectomy among patients with locally advanced bulky cervical cancer initially treated with cisplatin-based chemoradiation?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15504-e15504

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of perioperative CA-125 levels in patients with endometrial cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15573-e15573

2011

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 and ESR genotypes in adjuvant tamoxifen treatment for early breast cancer

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.142-142

2011

Link zum Volltext

Verfügbarkeit prüfen

CpG island methylator phenotype and KRAS mutation status as prognostic markers in patients with resected colorectal cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3595-3595

2011

Link zum Volltext

Verfügbarkeit prüfen

A single-arm, phase II feasibility study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.96-96

2011

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin, 5-fluorouracil, and folinic acid as first-line treatment in metastatic or recurrent gastric cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14646-e14646

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical significances of preoperative serum IL-6 and CRP level in operable gastric cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15591-e15591

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.057

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.057)
Mit Volltextzugriff
(1.056)

Publikationsform

Artikel
(1.057)

Sprache

Englisch
(1.057)
Japanisch
(46)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Oncology
(166)
Life Sciences & Biomedicine
(159)
Science & Technology
(159)
Humans
(154)
Female
(131)
Male
(125)
Adult
(106)
Middle Aged
(106)
Biological And Medical Sciences
(94)
Medical Sciences
(94)
Aged
(88)
Tumors
(49)
Cancer Research
(46)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(45)
Original Reports
(41)
Treatment Outcome
(37)
Aged, 80 And Over
(35)
Pharmacology. Drug Treatments
(35)
Neoplasm Staging
(34)
Antineoplastic Agents
(33)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB-FREE-00999 freely available EZB journals
(1.057)
Journals@Ovid Full Text
(1.057)
Publisher or Other Site
(1.057)
IngentaConnect Journals
(300)
Ingenta
(300)
MEDLINE
(154)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(2)

Menü

Weitere Dienste

Einstellungen

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial

Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial

Oxaliplatin, 5-FU, and leucovorin (FOLFOX) in advanced biliary tract cancer

The association of novel recurrent in-frame gene fusions with prognosis of diffuse gastric cancer

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Identification of a new cancer/testis antigen from small cell lung cancer

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

The clinical implication of comprehensive geriatric assessment in elderly Korean cancer patients receiving systemic chemotherapy

Proteome analysis of malignant pleural effusion

Clinical characteristics of an incident cohort of patients with resected squamous cell carcinoma of the head and neck (SCCHN) in the United Kingdom

Economic burden and patterns of care in patients with advanced hepatocellular carcinoma

Are there any candidates for adjuvant hysterectomy among patients with locally advanced bulky cervical cancer initially treated with cisplatin-based chemoradiation?

Prognostic impact of perioperative CA-125 levels in patients with endometrial cancer

CYP2D6 and ESR genotypes in adjuvant tamoxifen treatment for early breast cancer

CpG island methylator phenotype and KRAS mutation status as prognostic markers in patients with resected colorectal cancer

A single-arm, phase II feasibility study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Oxaliplatin, 5-fluorouracil, and folinic acid as first-line treatment in metastatic or recurrent gastric cancer

Clinical significances of preoperative serum IL-6 and CRP level in operable gastric cancer

Aktive Filter

Suchergebnisse filtern